Beijing Fino Weikang Biotechnology Co., Ltd.

Confirm

About Us

Contact Information

Join us

ABOUT US

Beijing PhenoVision Biotechnology Co., LTD

Beijing PhenoVision Biotechnology Co., LTD. (hereinafter referred to as " PhenoVision") was established in 2022 and is located in the Beijing Economic-Technological Development Area. The company has established a clinical translation and service center. The core members of the company have extensive experience in the development of biotechnological medicines and clinical diagnostic applications. They are committed to creating a new platform for spatial omics technology in the application of clinical translational medicine and precision healthcare. The company has strong technical and R&D capabilities, with business deployments in various provinces and key cities across the country.

Picture Name
Picture Name

Since its establishment, PhenoVision has always adhered to the core philosophy of "leading spatial omics technology innovation to empower precision medicine." With the purpose of "science, integrity, and win-win cooperation," the company continuously integrates technology platforms and expands the application of new technologies in clinical fields. In 2022, PhenoVision secured tens of millions of dollars in angel round financing from the renowned investment firm Oriza holdings, accelerating the company's development process. We maintain a serious and responsible attitude towards our clients, follow standardized operational procedures, and ensure the smooth implementation of plans and projects with efficient execution.

Since the establishment of the Spatial Omics Clinical Translation Center, the company has built a comprehensive technology platform that includes in situ detection at the protein, RNA, and DNA molecular levels, and has initiated several collaborative projects in the clinical and pharmaceutical fields. In the future, the company will continue to strive to build an innovative spatial omics technology platform and its applications, providing integrated solutions for clinical translational medicine and precision healthcare.

Since its inception, the company has always adhered to the business principles of prioritizing talent and establishing the enterprise with integrity. It has gathered elites from the industry, combining foreign technology, management practices, and corporate experience with the specific realities of domestic enterprises. The company has strived to enhance its management and marketing capabilities, enabling it to maintain competitiveness in fierce market competition and achieve rapid and stable development. Through in-depth cooperation with domestic professional clinical institutions, the company maintains a leading position in research and development. In terms of marketing, the company's members all possess extensive marketing experience and product knowledge, with work experience in large diagnostic enterprises. They are innovative and lead the development of the company.

Picture Name
Picture Name
Picture Name

CONTACT

Floor 3, Unit 1, Building 15, Jiajie Box Enterprise Exchange, Daxing District, Beijing

86-010-67873050

info@phenobiotech.com

Official public number two-dimensional code
Weekly content

online message

Submit Message